260 related articles for article (PubMed ID: 8227794)
1. Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
Alboni P; Razzolini R; Scarfò S; Paparella N; Fucà G; Pedini I; Chioin R
J Am Coll Cardiol; 1993 Nov; 22(5):1373-7. PubMed ID: 8227794
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
Sahar DI; Reiffel JA; Bigger JT; Squatrito A; Kidwell GA
Am Heart J; 1989 Mar; 117(3):562-8. PubMed ID: 2919535
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamics of idiopathic paroxysmal atrial fibrillation.
Alboni P; Scarfò S; Fucà G; Paparella N; Yannacopulu P
Pacing Clin Electrophysiol; 1995 May; 18(5 Pt 1):980-5. PubMed ID: 7659571
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic performances in patients treated with sotalol after electrical cardioversion of atrial fibrillation.
Dan GA; Gonţa A
Rom J Intern Med; 1997; 35(1-4):19-27. PubMed ID: 9562649
[TBL] [Abstract][Full Text] [Related]
5. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
6. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sotalol in patients with refractory atrial fibrillation or flutter.
Gallik DM; Kim SG; Ferrick KJ; Roth JA; Fisher JD
Am Heart J; 1997 Aug; 134(2 Pt 1):155-60. PubMed ID: 9313591
[TBL] [Abstract][Full Text] [Related]
8. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter].
Cruz Cruz F; Iturralde Torres P; Picos Bovio E; Medeiros Domingo A; Infante Vázquez O
Arch Inst Cardiol Mex; 1998; 68(6):482-91. PubMed ID: 10365224
[TBL] [Abstract][Full Text] [Related]
9. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
10. Sotalol for atrial tachycardias after surgery for congenital heart disease.
Beaufort-Krol GC; Bink-Boelkens MT
Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2125-9. PubMed ID: 9272523
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables.
Reimold SC; Lamas GA; Cantillon CO; Antman EM
Am Heart J; 1995 Jun; 129(6):1127-32. PubMed ID: 7754943
[TBL] [Abstract][Full Text] [Related]
12. Cardioversion with sotalol in selected patients with vagally and adrenergically mediated paroxysmal atrial fibrillation.
Yeşil M; Bayata S; Postaci N; Yücel O; Aslan O
Angiology; 1999 Sep; 50(9):729-33. PubMed ID: 10496499
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.
Tse HF; Lau CP
J Am Coll Cardiol; 2002 Dec; 40(12):2150-5. PubMed ID: 12505228
[TBL] [Abstract][Full Text] [Related]
14. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
[TBL] [Abstract][Full Text] [Related]
15. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
[TBL] [Abstract][Full Text] [Related]
16. Treatment of recent onset atrial fibrillation with intravenous sotalol and/or flecainide.
Peters FP; Braat SH; Heymeriks J; Wellens HJ
Neth J Med; 1998 Sep; 53(3):93-6. PubMed ID: 9803139
[TBL] [Abstract][Full Text] [Related]
17. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of VVI pacing on atrial and ventricular function in patients with sick sinus syndrome.
Paxinos G; Katritsis D; Kakouros S; Toutouzas P; Camm AJ
Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):728-34. PubMed ID: 9584304
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Bellandi F; Simonetti I; Leoncini M; Frascarelli F; Giovannini T; Maioli M; Dabizzi RP
Am J Cardiol; 2001 Sep; 88(6):640-5. PubMed ID: 11564387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
